NewEdge Advisors’s Counterpoint Quantitative Equity ETF CPAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.78M Buy
111,269
+77,610
+231% +$3.72M 0.02% 717
2026
Q1
$1.41M Buy
33,659
+8,541
+34% +$368K 0.01% 1299
2025
Q4
$1.01M Buy
25,118
+1,525
+6% +$60.4K ﹤0.01% 1485
2025
Q3
$932K Buy
23,593
+23,538
+42,796% +$869K ﹤0.01% 1431
2025
Q2
$2.04K Buy
+55
New +$1.86K ﹤0.01% 3619

Other funds holding CPAI

NewEdge Advisors's CPAI Position: Q2 2026 in Review

NewEdge Advisors increased its Counterpoint Quantitative Equity ETF (CPAI) stake by 231% in Q2 2026, buying an estimated $3.72M and bringing the position to 111,269 shares worth $5.78M. The position accounts for 0.02% of the portfolio, ranked #717.

NewEdge Advisors first reported a position in CPAI in Q2 2025 and has held it in 5 quarters since. 54 funds tracked by Wall St. Rank hold CPAI as of Q2 2026.

  • NewEdge Advisors held 111,269 shares of Counterpoint Quantitative Equity ETF worth $5.78M as of Q2 2026.
  • NewEdge Advisors bought 77,610 Counterpoint Quantitative Equity ETF shares in Q2 2026, an estimated $3.72M.
  • Counterpoint Quantitative Equity ETF made up 0.02% of NewEdge Advisors's portfolio in Q2 2026, its #717 holding.
  • NewEdge Advisors first reported a position in Counterpoint Quantitative Equity ETF in Q2 2025 and has held it in 5 quarters since.
  • 54 funds tracked by Wall St. Rank held Counterpoint Quantitative Equity ETF as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.